United States · Bill · S
S. 948 (108th)
Drug Company Gift Disclosure Act
Introduced
29 April 2003
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S5494-5495)
Sponsors
—
Subjects
Discovery layer
Source updated
18 August 2025
Summary
Drug Company Gift Disclosure Act - Amends the Federal Food, Drug, and Cosmetic Act to require drug manufacturers, packers, and distributors to disclose to the Commissioner of Food and Drugs the value, nature, and purpose of: (1) gifts made to covered health entities in connection with marketing activities; and (2) cash rebates, discounts, or any other financial consideration to any pharmaceutical benefit manager in connection with marketing activities. Makes such information available to the public, but retains the confidentiality of trade secrets. Establishes civil penalties for violations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 29 April 2003
Introduced in Senate (PDF)
Introduced in Senate · EN · 29 April 2003
Introduced in Senate
summary · EN · 29 April 2003
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/108th-congress/senate-bill/948
- Open data entity: https://api.congress.gov/v3/bill/108/s/948